Boehringer sells Biotrack line
This article was originally published in Clinica
Executive Summary
Medical Device Technologies has bought Boehringer Mannheim's Biotrack product line, including worldwide distribution rights, for $1.35 million. Boehringer has agreed to a minimum product purchase in Germany of $1.2 million per year for the next five years.